187 related articles for article (PubMed ID: 37297002)
1. Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.
Díaz-González Á; Mora E; Avetisyan G; Furió S; De la Puerta R; Gil JV; Liquori A; Villamón E; García-Hernández C; Santiago M; García-Ruiz C; Llop M; Ferrer-Lores B; Barragán E; García-Palomares S; Mayordomo E; Luna I; Vicente A; Cordón L; Senent L; Álvarez-Larrán A; Cervera J; De la Rubia J; Hernández-Boluda JC; Such E
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297002
[TBL] [Abstract][Full Text] [Related]
2. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
[TBL] [Abstract][Full Text] [Related]
3. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
[TBL] [Abstract][Full Text] [Related]
4. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
[TBL] [Abstract][Full Text] [Related]
5. Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements.
Coccaro N; Zagaria A; Anelli L; Tarantini F; Tota G; Conserva MR; Cumbo C; Parciante E; Redavid I; Ingravallo G; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137002
[TBL] [Abstract][Full Text] [Related]
6. High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance.
Yang H; Garcia-Manero G; Sasaki K; Montalban-Bravo G; Tang Z; Wei Y; Kadia T; Chien K; Rush D; Nguyen H; Kalia A; Nimmakayalu M; Bueso-Ramos C; Kantarjian H; Medeiros LJ; Luthra R; Kanagal-Shamanna R
Leukemia; 2022 Sep; 36(9):2306-2316. PubMed ID: 35915143
[TBL] [Abstract][Full Text] [Related]
7. Detection of cryptic balanced chromosomal rearrangements using high-resolution optical genome mapping.
Zhang S; Pei Z; Lei C; Zhu S; Deng K; Zhou J; Yang J; Lu D; Sun X; Xu C; Xu C
J Med Genet; 2023 Mar; 60(3):274-284. PubMed ID: 35710108
[TBL] [Abstract][Full Text] [Related]
8. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
[TBL] [Abstract][Full Text] [Related]
9. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).
Puiggros A; Ramos-Campoy S; Kamaso J; de la Rosa M; Salido M; Melero C; Rodríguez-Rivera M; Bougeon S; Collado R; Gimeno E; García-Serra R; Alonso S; Moro-García MA; García-Malo MD; Calvo X; Arenillas L; Ferrer A; Mantere T; Hoischen A; Schoumans J; Espinet B
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884436
[TBL] [Abstract][Full Text] [Related]
10. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
Rack K; De Bie J; Ameye G; Gielen O; Demeyer S; Cools J; De Keersmaecker K; Vermeesch JR; Maertens J; Segers H; Michaux L; Dewaele B
Am J Hematol; 2022 May; 97(5):548-561. PubMed ID: 35119131
[TBL] [Abstract][Full Text] [Related]
12. Optical Genome Mapping for Comprehensive Assessment of Chromosomal Aberrations and Discovery of New Fusion Genes in Pediatric B-Acute Lymphoblastic Leukemia.
Gao H; Xu H; Wang C; Cui L; Huang X; Li W; Yue Z; Tian S; Zhao X; Xue T; Xing T; Li J; Wang Y; Zhang R; Li Z; Wang T
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612032
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics.
Dai P; Zhu X; Pei Y; Chen P; Li J; Gao Z; Liang Y; Kong X
Mol Genet Genomic Med; 2022 Jun; 10(6):e1936. PubMed ID: 35384386
[TBL] [Abstract][Full Text] [Related]
14. Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid Leukemia.
Suttorp J; Lühmann JL; Behrens YL; Göhring G; Steinemann D; Reinhardt D; Neuhoff NV; Schneider M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565187
[TBL] [Abstract][Full Text] [Related]
15. Optical Genome Mapping as a New Tool to Overcome Conventional Cytogenetics Limitations in Patients with Bone Marrow Failure.
Iriondo J; Gómez A; Zubicaray J; Garcia-Martinez J; Abad L; Matesanz C; Giménez R; Galán A; Sanz A; Sebastián E; González de Pablo J; de la Cruz A; Ramírez M; Sevilla J
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790188
[TBL] [Abstract][Full Text] [Related]
16. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
[TBL] [Abstract][Full Text] [Related]
17. Optical genome mapping for prenatal diagnosis: A prospective study.
Goumy C; Guy Ouedraogo Z; Soler G; Eymard-Pierre E; Laurichesse H; Delabaere A; Gallot D; Bouchet P; Perthus I; Pebrel-Richard C; Gouas L; Salaun G; Salse J; Véronèse L; Tchirkov A
Clin Chim Acta; 2023 Nov; 551():117594. PubMed ID: 37832906
[TBL] [Abstract][Full Text] [Related]
18. Optical Genome Mapping for Cytogenetic Diagnostics in AML.
Nilius-Eliliwi V; Gerding WM; Schroers R; Nguyen HP; Vangala DB
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980569
[TBL] [Abstract][Full Text] [Related]
19. Optical Genome Mapping for a Patient with a Congenital Disorder and Chromosomal Translocation.
Ogiwara Y; Hattori A; Ikegawa K; Hasegawa Y; Kuroki Y; Miyado M; Fukami M
Cytogenet Genome Res; 2022; 162(11-12):617-624. PubMed ID: 37231804
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia.
Lühmann JL; Stelter M; Wolter M; Kater J; Lentes J; Bergmann AK; Schieck M; Göhring G; Möricke A; Cario G; Žaliová M; Schrappe M; Schlegelberger B; Stanulla M; Steinemann D
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
